The field of Advanced Therapy Medicinal Products (ATMPs) is rapidly developing world wide but also specifically in our Leiden Bio Science Park. Leiden University Medical Center (LUMC) cordially invites you to a thematic session on 'ATMP's, from idea to patient care' on February 29, 2024. Let’s get to know each other better!
In the LUMC we have more than 20 years of experience developing innovative cell and gene therapy applications. Over these years many ideas and results from our research labs and clinical departments were translated into ATMP products, were produced in our Good Manufacturing Practice (GMP) facility and have been tested in a multitude of LUMC, national and international clinical trials. The LUMC Center for Cell and Gene therapy (CCG) focusses on early product development and is eager to collaborate with academic, non-for-profit as well as commercial partners aiming to speed up development of new solution for our patients.
We would like to share our knowledge, expertise and production potential for the betterment of patient care. During this session we wish to discuss and identify a possible interest in collaboration as well as opportunities for professional training.
Who should take part?
This meeting is of interest to developers and manufacturers of ATMP's (scientists, Chemistry Manufacturing and Control staff, management, business developers).
15.00 - 15.30 Gathering
15.30 - 15.35 Welcome (Dr. Sandra Migchielsen, CIV Bio Sciences)
15.35 - 15.55 Center for Cell and Gene therapy manufacturing expertise (Dr. Pauline Meij, CCG, LUMC)
15.55 - 16.15 Product development for the failing immune system (Prof. Dr. Frank Staal, Dept. Immunology, LUMC)
16.15 - 16.30 Intermezzo
16.30 - 16.45 Tour Pharmacy dept / GMP facility for ATMPs (2 groups)
16.45 - 17.00 Tour Pharmacy dept / GMP facility for ATMPs (2 groups)
17.00 - 18.00 Drinks
If you have any questions, please do not hesitate to get in touch. We are looking forward to welcoming you.
Why these meetings? Based on the ambition to be an attractive innovation district, we want to collaborate more and better at the Leiden Bio Science Park and realize synergy in the field of 'human capital'. The CIV Bio Sciences partners take the lead by learning with and from each other (and others!) how Lifelong Development (LLO) of bio sciences professionals can be deployed. We also look at the need for education and training for professionals. The host partner determines the program for each meeting. In this way, the business community, education and government are jointly embarking on an expedition into this largely unexplored area. The CIV project 'Ecosystem Lifelong Learning' is part of the broader Human Capital Agenda LBSP and receives a contribution from Human Capital Akkoord Zuid-Holland. The focus is on vocational talent en training.